Disruption of dopamine transport by DDT and its metabolites

NeuroToxicology

Volumn 29, Issue 4, 2008, Pages 682-690

  Hatcher, Jaime M ^a,b   Delea, Kristin C ^a,b   Richardson, Jason R ^c   Pennell, Kurt D ^a,d   Miller, Gary W ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d Georgia Institute of Technology   (United States)

Author keywords

DDE; Dichlorodiphenylethane; Organochlorines; Parkinson's disease; Pesticides

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; CHLORPHENOTANE; DIELDRIN; DOPAMINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN DAMAGE; CELL MEMBRANE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALARIA; MALE; MEMBRANE VESICLE; MOSQUITO; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PEST CONTROL; PRIORITY JOURNAL; SYNAPTIC MEMBRANE;

ANIMALS; BEHAVIOR, ANIMAL; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DDT; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEUROBLASTOMA; PESTICIDES; PROTEIN CARBONYLATION; TRITIUM;

MUS;

EID: 46149099097     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2008.04.010     Document Type: Article

References (66)

1. Ascherio A., Chen H., Weisskopf M.G., O'Reilly E., McCullough M.L., Calle E.E., et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 60 (2006) 197-203
2. ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological profile for DDT, DDE, and DDD. U.S. Dept. of Health and Human Services-Public Health Service 2002; http://www.atsdr.cdc.gov/toxprofiles/phs35.html. Date last accessed: 8 September 2007.
3. Anon. Move against malaria. Nat Med 2006;12:863.
4. Berman S.B., Zigmond M.J., and Hastings T.G. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 67 (1996) 593-600
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3 (2000) 1301-1306
6. Bloomquist J.R., Barlow R.L., Gillette J.S., Li W., and Kirby M.L. Selective effects of insecticides on nigrostriatal dopaminergic nerve pathways. Neurotoxicology 23 (2002) 537-544
7. Carlsson A., and Fornstedt B. Possible mechanisms underlying the special vulnerability of dopaminergic neurons. Acta Neurol Scand Suppl 136 (1991) 16-18
8. Caudle W.M., Richardson J.R., Delea K.C., Guillot T.S., Wang M., Pennell K.D., et al. Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity. Toxicol Sci 92 (2006) 490-499
9. Caudle W.M., Richardson J.R., Wang M., and Miller G.W. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. Neurotoxicology 26 (2005) 721-728
10. Caudle W.M., Richardson J.R., Wang M.Z., Taylor T.N., Guillot T.S., McCormack A.L., et al. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27 (2007) 8138-8148
11. Chu S., Covaci A., and Schepens P. Levels and chiral signatures of persistent organochlorine pollutants in human tissues from Belgium. Environ Res 93 (2003) 167-176
12. Chun H.S., Gibson G.E., DeGiorgio L.A., Zhang H., Kidd V.J., and Son J.H. Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem 76 (2001) 1010-1021
13. Corrigan F.M., Murray L., Wyatt C.L., and Shore R.F. Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp Neurol 150 (1998) 339-342
14. Corrigan F.M., Wienburg C.L., Shore R.F., Daniel S.E., and Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 59 (2000) 229-234
15. Elwan M.A., Richardson J.R., Guillot T.S., Caudle W.M., and Miller G.W. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicol Appl Pharmacol 211 (2006) 188-197
16. Fleming L., Mann J.B., Bean J., Briggle T., and Sanchez-Ramos J.R. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol 36 (1994) 100-103
17. Fornstedt B., Brun A., Rosengren E., and Carlsson A. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J Neural Transm Park Dis Dement Sect 1 (1989) 279-295
18. Fornstedt B., and Carlsson A. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment. J Neural Transm 76 (1989) 155-161
19. Frigerio R., Sanft K.R., Grossardt B.R., Peterson B.J., Elbaz A., Bower J.H., et al. Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord 21 10 (2006) 1688-1692
20. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., and Richardson R.J. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50 (1998) 1346-1350
21. Grandjean P., White R.F., Sullivan K., Debes F., Murata K., Otto D.A., et al. Impact of contrast sensitivity performance on visually presented neurobehavioral tests in mercury-exposed children. Neurotoxicol Teratol 23 (2001) 141-146
22. Guillot, TS, Asress, SA, Richardson, JR, Glass, JD, Miller, GW. Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. J Mot Behav, in press.
23. Gunasekaran K., Sahu S.S., Jambulingam P., and Das P.K. DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health 10 (2005) 160-168
24. Gunderson E.L. Dietary intakes of pesticides, selected elements, and other chemicals: FDA Total Diet Study, June 1984-April 1986. J AOAC Int 78 (1995) 910-921
25. Gunderson E.L. FDA Total Diet Study, July 1986-April 1991, dietary intakes of pesticides, selected elements, and other chemicals. J AOAC Int 78 (1995) 1353-1363
26. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 97 (2006) 1634-1658
27. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1999), Oxford University Press, Inc., New York
28. Hatcher J.M., Richardson J.R., Guillot T.S., McCormack A.I., Di Monte D.A., Jones D.P., et al. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol 204 (2007) 619-630
29. IARC (International Agency for Research on Cancer). Occupational exposures in spraying and application of insecticides. IARC Monogr Eval Carcinog Risks Hum 53 (1991) 45-92
30. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 13 Suppl. 1 (1998) 24-34
31. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 53 Suppl. 3 (2003) S26-S36 discussion S36-28
32. Jones D.C., Lau S.S., and Monks T.J. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC Cells. J Pharmacol Exp Ther 311 (2004) 298-306
33. Kamrin M.A. Ch. 6: chlorinated hydrocarbons. Pesticide profiles: toxicity, environmental impact, and fate (1997), CRC Press/Lewis Publishers, Boca Raton p. 239-42
34. Kanthasamy A.G., Kitazawa M., Kanthasamy A., and Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology 26 (2005) 701-719
35. Kirby M.L., Barlow R.L., and Bloomquist J.R. Selective effects of cyclodiene insecticides on dopamine release in mammalian synaptosomes. Toxicol Appl Pharmacol 181 (2002) 89-92
36. Kitazawa M., Anantharam V., and Kanthasamy A.G. Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic Biol Med 31 (2001) 1473-1485
37. Kitazawa M., Anantharam V., and Kanthasamy A.G. Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 119 (2003) 945-964
38. In: Klaassen C.D. (Ed). Casarett & Doull's toxicology: the basic science of poisons (2001), McGraw-Hill, New York
39. LaVoie M.J., and Hastings T.G. Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J Neurochem 73 (1999) 2546-2554
40. Le Couteur D.G., McLean A.J., Taylor M.C., Woodham B.L., and Board P.G. Pesticides and Parkinson's disease. Biomed Pharmacother 53 (1999) 122-130
41. Matsumura F. Toxicology of insecticides (1985), Plenum Press, New York
42. McCormack A.L., Atienza J.G., Johnston L.C., Andersen J.K., Vu S., and Di Monte D.A. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J Neurochem 93 (2005) 1030-1037
43. Miller G.W., Kirby M.L., Levey A.I., and Bloomquist J.R. Heptachlor alters expression and function of dopamine transporters. Neurotoxicology 20 (1999) 631-637
44. Montine T.J., Picklo M.J., Amarnath V., Whetsell Jr. W.O., and Graham D.G. Neurotoxicity of endogenous cysteinylcatechols. Exp Neurol 148 (1997) 26-33
45. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22 (1999) 123-144
46. Partilla J.S., Dempsey A.G., Nagpal A.S., Blough B.E., Baumann M.H., and Rothman R.B. Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J Pharmacol Exp Ther 319 (2006) 237-246
47. Pennell K.D., Hatcher J.M., Caudle W.M., Richardson J.R., Gearing M., Levey A.I., et al. Elevated levels of dieldrin are associated with Parkinson's disease. Preprints for Extended Abstracts, 46(2): Special Symposium on Persistent, Bioaccumulative and Toxic Chemicals, Division of Environmental Chemistry. American Chemical Society 232nd National Meeting. San Francisco, CA (2006)
48. Pifl C., Zezula J., Spittler A., Kattinger A., Reither H., Caron M.G., et al. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter. FASEB J 15 (2001) 1607-1609
49. Priyadarshi A., Khuder S.A., Schaub E.A., and Priyadarshi S.S. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res 86 (2001) 122-127
50. Priyadarshi A., Khuder S.A., Schaub E.A., and Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 21 (2000) 435-440
51. Purkerson-Parker S., McDaniel K.L., and Moser V.C. Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor. Toxicol Sci 64 (2001) 216-223
52. Rabinovic A.D., Lewis D.A., and Hastings T.G. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101 (2000) 67-76
53. Ramachandiran S., Hansen J.M., Jones D.P., Richardson J.R., and Miller G.W. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol Sci 95 (2007) 163-171
54. Richardson J.R., Caudle W.M., Wang M., Dean E.D., Pennell K.D., and Miller G.W. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. Faseb J 20 (2006) 1695-1697
55. Richardson J.R., Quan Y., Sherer T.B., Greenamyre J.T., and Miller G.W. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88 (2005) 193-201
56. Rogan W.J., and Chen A. Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT). The Lancet 366 (2005) 763-773
57. Semchuk K.M., Love E.J., and Lee R.G. Parkinson's disease and exposure to rural environmental factors: a population based case-control study. Can J Neurol Sci 18 (1991) 279-286
58. Semchuk K.M., Love E.J., and Lee R.G. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42 (1992) 1328-1335
59. Smith A.G. DDT and its analogs. In: Kreiger R. (Ed). Handbook of pesticide toxicology. 2nd edition (2001), Academic Press, Inc., San Diego 1305-1343
60. Smythies J., and Galzigna L. The oxidative metabolism of catecholamines in the brain: a review. Biochim Biophys Acta 1380 (1998) 159-162
61. Son J.H., Chun H.S., Joh T.H., Cho S., Conti B., and Lee J.W. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J Neurosci 19 (1999) 10-20
62. Spencer J.P., Whiteman M., Jenner P., and Halliwell B. 5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J Neurochem 81 (2002) 122-129
63. Stephans S.E., Miller G.W., Levey A.I., and Greenamyre J.T. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells. Neurotoxicology 23 (2002) 569-580
64. Thiruchelvam M., McCormack A., Richfield E.K., Baggs R.B., Tank A.W., Di Monte D.A., et al. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 18 (2003) 589-600
65. Turusov V., Rakitsky V., and Tomatis L. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environ Health Perspect 110 (2002) 125-128
66. WHO (World Health Organization). WHO gives indoor use of DDT a clean bill of health for controlling malaria; 2006. http://www.who.int/mediacentre/news/releases/2006/pr50/en/index.html. Date last accessed: 8 May 2007.